China
· Delayed Price · Currency is CNY Bloomage BioTechnology Corporation Statistics
Total Valuation
Bloomage BioTechnology Corporation has a market cap or net worth of CNY 23.32 billion. The enterprise value is 22.88 billion.
| Market Cap | 23.32B |
| Enterprise Value | 22.88B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Aug 8, 2024 |
Share Statistics
Bloomage BioTechnology Corporation has 478.64 million shares outstanding. The number of shares has decreased by -0.35% in one year.
| Shares Outstanding | 478.64M |
| Shares Change (YoY) | -0.35% |
| Shares Change (QoQ) | +1.75% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 11.32% |
| Float | 149.90M |
Valuation Ratios
The trailing PE ratio is 45.99 and the forward PE ratio is 28.63.
| PE Ratio | 45.99 |
| Forward PE | 28.63 |
| PS Ratio | 4.03 |
| PB Ratio | 3.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.84, with an EV/FCF ratio of -157.67.
| EV / Earnings | 44.88 |
| EV / Sales | 3.94 |
| EV / EBITDA | 30.84 |
| EV / EBIT | 49.19 |
| EV / FCF | -157.67 |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 2.98.
| Current Ratio | 2.29 |
| Quick Ratio | 1.11 |
| Debt / Equity | 2.98 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | -1.44 |
| Interest Coverage | 56.22 |
Financial Efficiency
Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 4.06%.
| Return on Equity (ROE) | 7.20% |
| Return on Assets (ROA) | 3.42% |
| Return on Capital (ROIC) | 4.06% |
| Revenue Per Employee | 1.32M |
| Profits Per Employee | 115,398 |
| Employee Count | 4,655 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.39% in the last 52 weeks. The beta is 0.71, so Bloomage BioTechnology Corporation's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -47.39% |
| 50-Day Moving Average | 57.71 |
| 200-Day Moving Average | 61.16 |
| Relative Strength Index (RSI) | 27.21 |
| Average Volume (20 Days) | 1,491,469 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bloomage BioTechnology Corporation had revenue of CNY 5.81 billion and earned 509.71 million in profits. Earnings per share was 1.06.
| Revenue | 5.81B |
| Gross Profit | 4.22B |
| Operating Income | 465.09M |
| Pretax Income | 602.50M |
| Net Income | 509.71M |
| EBITDA | 682.44M |
| EBIT | 465.09M |
| Earnings Per Share (EPS) | 1.06 |
Balance Sheet
The company has 687.93 million in cash and 209.26 million in debt, giving a net cash position of 478.67 million or 1.00 per share.
| Cash & Cash Equivalents | 687.93M |
| Total Debt | 209.26M |
| Net Cash | 478.67M |
| Net Cash Per Share | 1.00 |
| Equity (Book Value) | 7.02B |
| Book Value Per Share | 14.39 |
| Working Capital | 1.55B |
Cash Flow
In the last 12 months, operating cash flow was 777.85 million and capital expenditures -922.93 million, giving a free cash flow of -145.09 million.
| Operating Cash Flow | 777.85M |
| Capital Expenditures | -922.93M |
| Free Cash Flow | -145.09M |
| FCF Per Share | -0.30 |
Margins
Gross margin is 72.64%, with operating and profit margins of 8.00% and 8.77%.
| Gross Margin | 72.64% |
| Operating Margin | 8.00% |
| Pretax Margin | 10.37% |
| Profit Margin | 8.77% |
| EBITDA Margin | 11.74% |
| EBIT Margin | 8.00% |
| FCF Margin | -2.50% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 0.78%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 0.78% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 1.97% |
| Buyback Yield | 0.35% |
| Shareholder Yield | 1.13% |
| Earnings Yield | 2.17% |
| FCF Yield | -0.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |